NEW YORK (AP) _ Rocket Pharmaceuticals Inc. (RCKT) on Wednesday reported a loss of $19.5 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of 43 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
Rocket Pharmaceuticals shares have increased 26% since the beginning of the year. The stock has increased almost 8% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RCKT at https://www.zacks.com/ap/RCKT